Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Enterprise Value (2016 - 2025)

Cumberland Pharmaceuticals' Enterprise Value history spans 16 years, with the latest figure at -$11.8 million for Q4 2025.

  • For Q4 2025, Enterprise Value rose 35.52% year-over-year to -$11.8 million; the TTM value through Dec 2025 reached -$11.8 million, up 35.52%, while the annual FY2025 figure was -$11.8 million, 35.52% up from the prior year.
  • Enterprise Value for Q4 2025 was -$11.8 million at Cumberland Pharmaceuticals, up from -$15.5 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$11.8 million in Q4 2025 and bottomed at -$27.3 million in Q4 2021.
  • The 5-year median for Enterprise Value is -$18.5 million (2022), against an average of -$19.3 million.
  • The largest annual shift saw Enterprise Value dropped 12.88% in 2024 before it skyrocketed 35.52% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$27.3 million in 2021, then increased by 26.43% to -$20.1 million in 2022, then grew by 6.02% to -$18.8 million in 2023, then grew by 3.04% to -$18.3 million in 2024, then surged by 35.52% to -$11.8 million in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Enterprise Value are -$11.8 million (Q4 2025), -$15.5 million (Q3 2025), and -$16.4 million (Q2 2025).